Uridine and Vitamin B12: study protocols
4 study groups took Uridine together with Vitamin B12. These are the doses the studies gave. They are not a recommendation.
Fewer than 5 study groups in one unit match, too few to draw the chart.
Commonly used together
4 of 4 study groups took Uridine and Vitamin B12 with something else, but nothing that 3 or more different studies gave.
4 study groups
| Study | ||||
|---|---|---|---|---|
| [Effect of the Nucleus CMP forte in 46 patients with progressive spastic paraparesis. Randomized and blind study] 1996 · Nucleus CMP forte · Adults aged 25–79 with idiopathic or HTLV-1-associated progressive spastic paraparesis | 9 mg | 6 mg | 26 weeks | 22 |
| Evaluation of the Efficacy of the Addition of a Combination of Pyrimidine Nucleotides and Vitamin B1 and B12 to Standard Treatment in the Management of Painful Radiculopathy and in the Quality of Life of Patients 2024 · experimental treatment group · Adults aged 18–85 of both sexes with painful radiculopathy of any etiology, upper neuropathic pain, and pain VAS ≥60 mm | 300 mg | 1.49 g | 8 weeks | 63 |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication. | 625 mg | 3 mcg | 24 weeks | 501 |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2. | 625 mg | 3 mcg | 24 weeks | 201 |